| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-01-22 10:50 Tx date 2025-05-21 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+40,000 vol |
200,842 | |
| Filed 2025-02-06 14:32 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: LifeX Seed LLC (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-276,816 vol |
30,758 | |
| Filed 2025-02-06 14:30 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: Cyto Ventures Fund I, L.P. (Control or Direction)
|
Common Shares
37 - Stock split or consolidation
|
-1,897,336 vol |
210,816 | |
| Filed 2025-02-06 14:29 Tx date 2025-01-27 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-1,447,581 vol |
160,842 | |
| Filed 2025-01-06 18:19 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,608,423 | ||
| Filed 2025-01-06 18:19 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: Cyto Ventures Fund I, L.P. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,108,152 | ||
| Filed 2025-01-06 18:18 Tx date 2024-12-11 |
$SHRX
Sharp Therapeutics Corp. |
Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: LifeX Seed LLC (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
307,574 |